BRPI0913934A2 - compostos tendo propriedades antivirais - Google Patents

compostos tendo propriedades antivirais

Info

Publication number: BRPI0913934A2
Authority: BR; Brazil
Prior art keywords: compounds; antiviral properties; antiviral; properties
Prior art date: 2008-07-02

Application number

BRPI0913934A

Other languages

English (en)

Inventor

David Ian Rhodes

Eric Dale Jones

Giang Thanh Le

John Deadman

Lisa Jane Winfield

Neeranat Thienthong

Nicholas Andrew Van De Graff

Original Assignee

Avexa Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-02

Filing date

2009-07-02

Publication date

2015-10-20

2008-07-02 Priority claimed from AU2008903407A external-priority patent/AU2008903407A0/en

2009-07-02 Application filed by Avexa Ltd filed Critical Avexa Ltd

2015-10-20 Publication of BRPI0913934A2 publication Critical patent/BRPI0913934A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Communicable Diseases (AREA)
Veterinary Medicine (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BRPI0913934A 2008-07-02 2009-07-02 compostos tendo propriedades antivirais BRPI0913934A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
AU2008903407A AU2008903407A0 (en)		2008-07-02	Compounds having antiviral properties
US16193109P	2009-03-20	2009-03-20
PCT/AU2009/000858 WO2010000032A1 (en)	2008-07-02	2009-07-02	Compounds having antiviral properties

Publications (1)

Publication Number	Publication Date
BRPI0913934A2 true BRPI0913934A2 (pt)	2015-10-20

Family

ID=41465417

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0913934A BRPI0913934A2 (pt)	2008-07-02	2009-07-02	compostos tendo propriedades antivirais

Country Status (14)

Country	Link
US (2)	US8318732B2 (pt)
EP (2)	EP2759544A1 (pt)
JP (1)	JP5535204B2 (pt)
CN (1)	CN102143962B (pt)
AU (1)	AU2009266421B2 (pt)
BR (1)	BRPI0913934A2 (pt)
CA (1)	CA2729663A1 (pt)
ES (1)	ES2459046T3 (pt)
IL (1)	IL210207A0 (pt)
MX (1)	MX2011000149A (pt)
NZ (1)	NZ590126A (pt)
PL (1)	PL2212324T3 (pt)
SG (1)	SG192452A1 (pt)
WO (1)	WO2010000032A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2408654T3 (es) *	2008-07-02	2013-06-21	Avexa Limited	Tiazopirimidinonas y uso de las mismas
FR2947272B1 (fr) *	2009-06-29	2014-09-26	Univ Paris Curie	Utilisation d'arn interferents pour le traitement d'une infection par le vih
AU2011221037A1 (en) *	2010-02-26	2012-09-06	Japan Tobacco Inc.	1,3,4,8-tetrahydro-2H-pyrido[1,2-a]pyrazine derivative and use of same as HIV integrase inhibitor
US8846659B2 (en) *	2010-12-10	2014-09-30	Bristol-Myers Squibb Company	HIV integrase inhibitors
EP3082820B1 (en)	2013-12-19	2022-07-20	PTC Therapeutics, Inc.	Methods for modulating the amount of rna transcripts
EP3138840B1 (en) *	2014-04-28	2020-09-23	Jiangsu Kanion Pharmaceutical Co., Ltd.	Thiadiazolidine derivative as anti-enterovirus 71
EP4249472A3 (en)	2015-05-30	2023-12-13	PTC Therapeutics, Inc.	Methods for modulating rna splicing
EA201800367A1 (ru)	2015-12-10	2019-02-28	ПиТиСи ТЕРАПЬЮТИКС, ИНК.	Способы лечения болезни хантингтона
US20180096362A1 (en) *	2016-10-03	2018-04-05	Amy Ashley Kwan	E-Commerce Marketplace and Platform for Facilitating Cross-Border Real Estate Transactions and Attendant Services
EP3544435A4 (en)	2016-11-28	2020-11-04	PTC Therapeutics, Inc.	RNA SPLICE MODULATION PROCESSES
JP7376471B2 (ja)	2017-06-05	2023-11-08	ピーティーシーセラピューティクス，インコーポレイテッド	ハンチントン病を処置するための化合物
WO2018232039A1 (en)	2017-06-14	2018-12-20	Ptc Therapeutics, Inc.	Methods for modifying rna splicing
BR112019027717A2 (pt)	2017-06-28	2020-07-28	Ptc Therapeutics, Inc.	métodos para tratar a doença de huntington
US11395822B2 (en)	2017-06-28	2022-07-26	Ptc Therapeutics, Inc.	Methods for treating Huntington's disease
AU2019243048A1 (en)	2018-03-27	2020-10-15	Ptc Therapeutics, Inc.	Compounds for treating Huntington's disease
SI3814357T1 (sl)	2018-06-27	2024-09-30	Ptc Therapeutics, Inc.	Heterociklične in heteroarilne spojine za zdravljenje Huntingtonove bolezni
BR112020026534A2 (pt)	2018-06-27	2021-03-23	Ptc Therapeutics, Inc.	Compostos de heteroarila para o tratamento da doença de huntington
WO2020005882A1 (en)	2018-06-27	2020-01-02	Ptc Therapeutics, Inc.	Heteroaryl compounds for treating huntington's disease
HUE065762T2 (hu) *	2019-06-19	2024-06-28	Viiv Healthcare Uk No 5 Ltd	Pirido[2,3-d]pirimidin-származékok mint a humán immunhiányos vírus replikációjának gátlói
AU2020394867A1 (en)	2019-12-02	2022-05-26	Storm Therapeutics Limited	Polyheterocyclic compounds as METTL3 inhibitors
CN114751902B (zh) *	2021-01-08	2024-11-22	正大天晴药业集团股份有限公司	一种4H-吡啶并[1,2-a]嘧啶-4-酮化合物的制备方法
WO2024260929A1 (en) *	2023-06-19	2024-12-26	F. Hoffmann-La Roche Ag	Trem2 agonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK3042894T1 (da)	2001-08-10	2016-11-07	Shionogi & Co	Antiviralt middel
TW200526635A (en) *	2003-12-22	2005-08-16	Shionogi & Co	Hydroxypyrimidinone derivative having HIV integrase inhibitory activity
US7273859B2 (en) *	2004-05-12	2007-09-25	Bristol-Myers Squibb Company	HIV integrase inhibitors: cyclic pyrimidinone compounds
WO2007039218A1 (en) *	2005-10-04	2007-04-12	Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa	Hiv integrase inhibitors
JP2008019644A (ja)	2006-07-13	2008-01-31	Hitoshi Koide	石油または天然ガスの増進回収方法及びその増進回収システム
EP2269992A1 (en)	2006-12-22	2011-01-05	Avexa Limited	Bicyclic pyrimidinones for the treatment of viral infections
US8431581B2 (en)	2008-07-02	2013-04-30	Avexa Limited	Imidazopyrimidines and uses thereof

2009
- 2009-07-02 MX MX2011000149A patent/MX2011000149A/es active IP Right Grant
- 2009-07-02 EP EP14161042.8A patent/EP2759544A1/en not_active Withdrawn
- 2009-07-02 NZ NZ590126A patent/NZ590126A/xx not_active IP Right Cessation
- 2009-07-02 ES ES09771849.8T patent/ES2459046T3/es active Active
- 2009-07-02 AU AU2009266421A patent/AU2009266421B2/en not_active Ceased
- 2009-07-02 CN CN200980134068.6A patent/CN102143962B/zh not_active Expired - Fee Related
- 2009-07-02 SG SG2013050398A patent/SG192452A1/en unknown
- 2009-07-02 EP EP09771849.8A patent/EP2212324B1/en not_active Not-in-force
- 2009-07-02 CA CA2729663A patent/CA2729663A1/en not_active Abandoned
- 2009-07-02 JP JP2011515028A patent/JP5535204B2/ja not_active Expired - Fee Related
- 2009-07-02 BR BRPI0913934A patent/BRPI0913934A2/pt not_active IP Right Cessation
- 2009-07-02 US US12/734,036 patent/US8318732B2/en not_active Expired - Fee Related
- 2009-07-02 PL PL09771849T patent/PL2212324T3/pl unknown
- 2009-07-02 WO PCT/AU2009/000858 patent/WO2010000032A1/en not_active Ceased
2010
- 2010-12-23 IL IL210207A patent/IL210207A0/en unknown
2012
- 2012-09-13 US US13/614,049 patent/US8563562B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20130059865A1 (en)	2013-03-07
MX2011000149A (es)	2011-02-24
EP2212324A4 (en)	2011-01-19
AU2009266421B2 (en)	2013-07-11
CN102143962B (zh)	2015-03-11
IL210207A0 (en)	2011-03-31
JP5535204B2 (ja)	2014-07-02
EP2212324A1 (en)	2010-08-04
US8318732B2 (en)	2012-11-27
PL2212324T3 (pl)	2014-11-28
WO2010000032A1 (en)	2010-01-07
EP2212324B1 (en)	2014-03-26
US20110039842A1 (en)	2011-02-17
US8563562B2 (en)	2013-10-22
SG192452A1 (en)	2013-08-30
ES2459046T3 (es)	2014-05-07
JP2011526248A (ja)	2011-10-06
EP2759544A1 (en)	2014-07-30
CN102143962A (zh)	2011-08-03
NZ590126A (en)	2012-11-30
CA2729663A1 (en)	2010-01-07
AU2009266421A1 (en)	2010-01-07

Publication	Publication Date	Title
BRPI0913934A2 (pt)	2015-10-20	compostos tendo propriedades antivirais
EP2233838A4 (en)	2013-01-09	COOKER
EP2170350A4 (en)	2011-09-28	SUBSTITUTED IMIDAZOHETEROCYCLES
ATE542825T1 (de)	2012-02-15	Substituierte piperidino-dihydrothienopyrimidine
BRPI0821573A2 (pt)	2016-08-09	benzofuropirimidonas
ATE501136T1 (de)	2011-03-15	Imidazopyridinone
ATE514696T1 (de)	2011-07-15	Diphenyl-dihydro-imidazopyridinone
BRPI0814519A2 (pt)	2014-09-30	Organopolissiloxano
BRPI0811451A2 (pt)	2014-11-04	Exopolissacarídeo
BRPI0815547A2 (pt)	2015-02-10	Depsipeptídeos cícliocos
BRPI0812840A2 (pt)	2014-12-09	2-imidazolinas
DK2155273T3 (da)	2013-04-22	Lugtregulerende genstand
AT505058A3 (de)	2008-12-15	Türschliesssystem
BRPI0812994A2 (pt)	2014-12-23	Microbiocidas
DE112008001216A5 (de)	2010-02-04	Magnetronplasmaanlage
ATE506032T1 (de)	2011-05-15	Endoprothesenkomponente
DE112008002200A5 (de)	2010-09-23	Sperrsynchronisiervorrichtung
CU20090155A7 (es)	2011-04-26	Macrolidos
DE112008001534A5 (de)	2010-03-18	Anreihgussform
DE102007038931A8 (de)	2009-06-18	Fadenlagennähwirkstoffe
AT9563U3 (de)	2008-05-15	Wirbelsäulenzuggurtung
AT504425B8 (de)	2008-09-15	Portioniersteuerung
AT10777U2 (de)	2009-10-15	Steckschlüsseleinsatz
UA17337S (uk)	2008-09-25	Профіль
UA15445S (uk)	2007-12-10	Профіль

Legal Events

Date	Code	Title	Description
2016-09-20	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 7A ANUIDADE.
2017-01-10	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.
2017-05-30	B25H	Request for change of headquarter rejected	Owner name: AVEXA LIMITED (AU)